Home LiteratureArticle Details
PMID: 24991008 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples.

Journal of virology ·Vol. 88 ·No. 18 ·2014-09-00 ·Pages 10662-72

Kwok H, Wu CW, Palser AL, Kellam P, Sham PC, Kwong DL, Chiang AK

Abstract

Undifferentiated nasopharyngeal carcinoma (NPC) has a 100% association with Epstein-Barr virus (EBV). However, only three EBV genomes isolated from NPC patients have been sequenced to date, and the role of EBV genomic variations in the pathogenesis of NPC is unclear. We sought to obtain the sequences of EBV genomes in multiple NPC biopsy specimens in the same geographic location in order to reveal their sequence diversity. Three published EBV (B95-8, C666-1, and HKNPC1) genomes were first resequenced using the sequencing workflow of target enrichment of EBV DNA by hybridization, followed by next-generation sequencing, de novo assembly, and joining of contigs by Sanger sequencing. The sequences of eight NPC biopsy specimen-derived EBV (NPC-EBV) genomes, designated HKNPC2 to HKNPC9, were then determined. They harbored 1,736 variations in total, including 1,601 substitutions, 64 insertions, and 71 deletions, compared to the reference EBV. Furthermore, genes encoding latent, early lytic, and tegument proteins and glycoproteins were found to contain nonsynonymous mutations of potential biological significance. Phylogenetic analysis showed that the HKNPC6 and -7 genomes, which were isolated from tumor biopsy specimens of advanced metastatic NPC cases, were distinct from the other six NPC-EBV genomes, suggesting the presence of at least two parental lineages of EBV among the NPC-EBV genomes. In conclusion, much greater sequence diversity among EBV isolates derived from NPC biopsy specimens is demonstrated on a whole-genome level through a complete sequencing workflow. Large-scale sequencing and comparison of EBV genomes isolated from NPC and normal subjects should be performed to assess whether EBV genomic variations contribute to NPC pathogenesis. This study established a sequencing workflow from EBV DNA capture and sequencing to de novo assembly and contig joining. We reported eight newly sequenced EBV genomes isolated from primary NPC biopsy specimens and revealed the sequence diversity on a whole-genome level among these EBV isolates. At least two lineages of EBV strains are observed, and recombination among these lineages is inferred. Our study has demonstrated the value of, and provided a platform for, genome sequencing of EBV.

MeSH Terms
Adult Base Sequence Biopsy Carcinoma Female Genetic Variation Genome, Viral Herpesvirus 4, Human/classification,genetics,isolation & purification Humans Male Middle Aged Molecular Sequence Data Mutagenesis, Insertional Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms/virology Phylogeny Sequence Deletion Young Adult
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Kwok H
Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Wu C W
Centre for Genomic Sciences, The Hong Kong Jockey Club Building for Interdisciplinary Research, The University of Hong Kong, Hong Kong, China.
Palser A L
Wellcome Trust Sanger Institute, London, United Kingdom.
Kellam P
Wellcome Trust Sanger Institute, London, United Kingdom.
Sham P C
Centre for Genomic Sciences, The Hong Kong Jockey Club Building for Interdisciplinary Research, The University of Hong Kong, Hong Kong, China.
Kwong D L W
Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Chiang A K S
Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China chiangak@hku.hk.
References (53)
53 references, click to expand
  1. Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas.
    Cell Rep. 2013 Oct 31;5(2):458-70 PMID: 24120866
  2. Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.
    Virology. 1983 Mar;125(2):287-98 PMID: 6301144
  3. Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology.
    BMC Genomics. 2013 Nov 19;14:804 PMID: 24252203
  4. Multiple alignment of DNA sequences with MAFFT.
    Methods Mol Biol. 2009;537:39-64 PMID: 19378139
  5. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
    Int J Cancer. 1999 Sep 24;83(1):121-6 PMID: 10449618
  6. Fast and accurate short read alignment with Burrows-Wheeler transform.
    Bioinformatics. 2009 Jul 15;25(14):1754-60 PMID: 19451168
  7. Specific capture and whole-genome sequencing of viruses from clinical samples.
    PLoS One. 2011;6(11):e27805 PMID: 22125625
  8. Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains.
    J Virol. 2013 Jan;87(2):1172-82 PMID: 23152513
  9. Potential selection of LMP1 variants in nasopharyngeal carcinoma.
    J Virol. 2004 Jan;78(2):868-81 PMID: 14694118
  10. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.
    J Virol. 2005 Dec;79(24):15323-30 PMID: 16306603
  11. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    J Gen Virol. 1988 May;69 ( Pt 5):1051-65 PMID: 2836550
  12. Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.
    PLoS One. 2012;7(5):e36939 PMID: 22590638
  13. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.
    Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4419-24 PMID: 19237563
  14. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
    J Virol. 1990 Sep;64(9):4084-92 PMID: 2166806
  15. Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients.
    Virus Res. 2001 Dec 4;81(1-2):133-42 PMID: 11682132
  16. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
    Int J Cancer. 1998 May 4;76(3):399-406 PMID: 9579578
  17. Structural genomics of the Epstein-Barr virus.
    Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1276-85 PMID: 17001105
  18. The genome of Epstein-Barr virus type 2 strain AG876.
    Virology. 2006 Jun 20;350(1):164-70 PMID: 16490228
  19. Epstein-Barr virus entry.
    J Virol. 2007 Aug;81(15):7825-32 PMID: 17459936
  20. The Jalview Java alignment editor.
    Bioinformatics. 2004 Feb 12;20(3):426-7 PMID: 14960472
  21. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.
    J Virol. 1999 Jan;73(1):152-60 PMID: 9847317
  22. The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity.
    J Virol. 2009 May;83(9):4345-53 PMID: 19244336
  23. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.
    Mol Biol Evol. 2011 Oct;28(10):2731-9 PMID: 21546353
  24. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.
    J Gen Virol. 2003 Jun;84(Pt 6):1443-1450 PMID: 12771413
  25. Velvet: algorithms for de novo short read assembly using de Bruijn graphs.
    Genome Res. 2008 May;18(5):821-9 PMID: 18349386
  26. Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.
    J Virol. 1982 Jul;43(1):262-72 PMID: 6180174
  27. RDP3: a flexible and fast computer program for analyzing recombination.
    Bioinformatics. 2010 Oct 1;26(19):2462-3 PMID: 20798170
  28. Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology.
    J Virol. 2011 Nov;85(21):11291-9 PMID: 21880770
  29. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.
    J Immunol. 2011 Jul 1;187(1):92-101 PMID: 21622860
  30. Epitope mapping of gp350/220 conserved domain of epstein barr virus to develop nasopharyngeal carcinoma (npc) vaccine.
    Bioinformation. 2012;8(10):479-82 PMID: 22715303
  31. Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients.
    J Clin Virol. 2010 Feb;47(2):161-9 PMID: 20022297
  32. Lineage structures in the genome sequences of three Epstein-Barr virus strains.
    Virology. 2007 Mar 1;359(1):1-5 PMID: 17097710
  33. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma.
    Cancer Lett. 2004 Jul 28;211(1):11-8 PMID: 15194212
  34. High recombination rate in herpes simplex virus type 1 natural populations suggests significant co-infection.
    Infect Genet Evol. 2004 Jun;4(2):115-23 PMID: 15157629
  35. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.
    Annu Rev Immunol. 2007;25:587-617 PMID: 17378764
  36. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
    Ann Otol Rhinol Laryngol. 1984 Sep-Oct;93(5 Pt 1):477-82 PMID: 6093669
  37. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  38. Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene.
    J Gen Virol. 2001 Oct;82(Pt 10):2393-2404 PMID: 11562533
  39. Integrative genomics viewer.
    Nat Biotechnol. 2011 Jan;29(1):24-6 PMID: 21221095
  40. Epstein-Barr virus. The B95-8 strain map.
    Methods Mol Biol. 2001;174:3-12 PMID: 11357658
  41. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
    World J Surg Oncol. 2008 Feb 15;6:18 PMID: 18275617
  42. VarScan: variant detection in massively parallel sequencing of individual and pooled samples.
    Bioinformatics. 2009 Sep 1;25(17):2283-5 PMID: 19542151
  43. Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.
    Genome Biol Evol. 2014 Apr;6(4):846-60 PMID: 24682154
  44. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.
    J Virol. 2003 Nov;77(21):11507-16 PMID: 14557636
  45. Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa.
    Int J Cancer. 1998 Feb 9;75(4):497-503 PMID: 9466647
  46. The Sequence Alignment/Map format and SAMtools.
    Bioinformatics. 2009 Aug 15;25(16):2078-9 PMID: 19505943
  47. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    J Biomed Sci. 2005 Dec;12(6):925-36 PMID: 16307312
  48. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
    Virus Genes. 2008 Oct;37(2):273-81 PMID: 18663567
  49. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.
    Int J Cancer. 2006 Apr 15;118(8):1977-83 PMID: 16287066
  50. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
    Laryngoscope. 2006 Apr;116(4):541-6 PMID: 16585856
  51. Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells.
    J Gen Virol. 2001 Oct;82(Pt 10):2373-2383 PMID: 11562531
  52. Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1.
    Infect Agent Cancer. 2013 Aug 02;8(1):29 PMID: 23915735
  53. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Proc Natl Acad Sci U S A. 1973 Jan;70(1):190-4 PMID: 4346033
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
1098-5514
Published
2014-09-00
Epub
2014-00-02
Pages
10662-72
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC4178900
Subset
IM
Databases
GENBANK
KF992564, KF992565, KF992566, KF992567, KF992568, KF992569, KF992570, KF992571
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com